Cargando…
A randomized DBPC trial to determine the optimal effective and safe dose of a SLIT‐birch pollen extract for the treatment of allergic rhinitis: results of a phase II study
BACKGROUND: Sublingual immunotherapy (SLIT) is a potential efficacious and safe treatment option for patients with respiratory, IgE‐mediated allergic diseases. A combined tolerability, dose‐finding study with a sublingual liquid birch pollen preparation (SB) was conducted. METHODS: Two hundred and s...
Autores principales: | Pfaar, O., van Twuijver, E., Boot, J. D., Opstelten, D. J. E., Klimek, L., van Ree, R., Diamant, Z., Kuna, P., Panzner, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057302/ https://www.ncbi.nlm.nih.gov/pubmed/26417901 http://dx.doi.org/10.1111/all.12760 |
Ejemplares similares
-
A prospective study comparing the efficacy and safety of two sublingual birch allergen preparations
por: Klimek, Ludger, et al.
Publicado: (2014) -
5-grass-pollen SLIT effectiveness in seasonal allergic rhinitis: Impact of sensitization to subtropical grass pollen
por: van Nunen, Sheryl A., et al.
Publicado: (2022) -
Real‐world benefits of allergen immunotherapy for birch pollen‐associated allergic rhinitis and asthma
por: Wahn, Ulrich, et al.
Publicado: (2018) -
A Cost-Utility Analysis of SQ(®) Tree SLIT-Tablet versus Placebo in the Treatment of Birch Pollen Allergic Rhinitis from a Swedish Societal Perspective
por: Pollock, Richard F, et al.
Publicado: (2023) -
Systemic and local eosinophil inflammation during the birch pollen season in allergic patients with predominant rhinitis or asthma
por: Kämpe, Mary, et al.
Publicado: (2007)